NI
CNTX icon

Nextech Invest’s Context Therapeutics CNTX Stock Holding History

Nextech Invest’s Portfolio CNTX Stock Details CNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11M Hold
7,419,355
– – 0.2% 14
2026
Q1 		$19.4M Hold
7,419,355
– – 1.37% 10
2025
Q4 		$10.9M Hold
7,419,355
– – 1.05% 12
2025
Q3 		$7.19M Hold
7,419,355
– – 1.09% 10
2025
Q2 		$4.86M Hold
7,419,355
– – 0.92% 14
2025
Q1 		$4.54M Hold
7,419,355
– – 1.06% 12
2024
Q4 		$7.79M Hold
7,419,355
– – 1.26% 13
2024
Q3 		$14.5M Hold
7,419,355
– – 2.04% 13
2024
Q2 		$14.9M Buy
+7,419,355
New +$12.8M 2.5% 12

Other funds holding CNTX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nextech Invest's CNTX Position: Q2 2026 in Review

Nextech Invest held its Context Therapeutics (CNTX) position steady in Q2 2026 at 7,419,355 shares worth $4.11M. The position accounts for 0.2% of the portfolio, ranked #14.

Nextech Invest first reported a position in CNTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.4M in Q1 2026. 79 funds tracked by Wall St. Rank hold CNTX as of Q2 2026.

  • Nextech Invest held 7,419,355 shares of Context Therapeutics worth $4.11M as of Q2 2026.
  • Nextech Invest left its Context Therapeutics share count unchanged in Q2 2026.
  • Context Therapeutics made up 0.2% of Nextech Invest's portfolio in Q2 2026, its #14 holding.
  • Nextech Invest first reported a position in Context Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Nextech Invest's Context Therapeutics position peaked at $19.4M in Q1 2026.
  • 79 funds tracked by Wall St. Rank held Context Therapeutics as of Q2 2026.

Based on Nextech Invest's 13F filing for Q2 2026, filed 14 Aug 2026.